Clinical Trials

Overview

About this study

The purpose of this study is to summarize the clinical, morphological, and pathological features of patients with hypertrophic cardiomyopathy (HCM) and end systolic cavity obliteration, to describe the surgical technique of enlarging the left ventricular (LV) cavity through the transapical approach to myectomy, to compare patients’ hemodynamic alterations before and after transapical septal myectomy, to assess patients’ functional recovery after apical myectomy, and to evaluate the survival rate of these targeted surgical patients.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Participating Mayo Clinic locations

More information